After all else failed, researches trained patient's immune cells to identify and fight cancerous cells.
A research study shows patients with advanced breast cancer tied to an inherited gene mutation treated with an experimental Pfizer Inc drug went about three months longer before their disease worsened.
Novartis considers its Kisqali to be among a dozen new medicines with blockbuster potential.
Subscribe to our Youtube channel for all latest in-depth, on the ground reporting from around the world.
Copyright © 2023 TRT World.